Back to Resource Center

Bioavailability/Bioequivalence Strategies for MPTs – Feasibility and Risks

January 2016

Click for full info +

Bioavailability/Bioequivalence Strategies for MPTs – Feasibility and Risks

Bioavailability/Bioequivalence Strategies for MPTs - Feasibility and Risks
26 January 2017

This live webinar focused on critical conversations around bioavailability and bioequivalence strategies for MPTs, including feasibility and risks. The webinar featured a presentation by Charles DiLiberti of Montclair Bioequivalence Services and a facilitated discussion with Laneta Dorflinger of FHI 360 and Joseph Romano of the IMPT.

• View Webinar Recording

DiLiberti,C., Dorflinger, L., Romano, J.
In this Webinar:
Product Type(s):

  • MPTs
    • Topic(s):

  • MPTs
  • Risk

    • Full Info:


    Resource Type:

    Webinar
    Webinar

    Authors: DiLiberti,C., Dorflinger, L., Romano, J.

    Health Risks(s):

    • General SRH
    • HIV
    • STI / STD
    • Unintended Pregnancy

    Product type(s):

    • MPTs

    Topic(s):

    • Regulatory

    Back to Resource Center